Stock Events

Stock Events

Spyre Therapeutics (SYRE) Q1 2017 Earnings

18MayExpected

Q2 2016

Q3 2016

Q4 2016

Q1 2017

-0.56

-0.52

-0.47

-0.43

Details

Expected EPS

-0.47

Actual EPS

-0.47

Surprise EPS

0

Surprise Percent

+0%

Description

Spyre Therapeutics (SYRE) has reported earnings of -0.47 per share for Q1 2017.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.